These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11009543)

  • 41. [High maternal mortality in the world's poorest countries].
    Riska O
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):546. PubMed ID: 19282903
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug access in poor countries].
    Sebbag R
    Bull Acad Natl Med; 2007 Nov; 191(8):1601-2. PubMed ID: 18666459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Control of the quality of antiretroviral medicines used in Senegal].
    Sarr SO; Diop A; Diop YM; Ndiaye B; Koffi YM; Fall D; Smine A
    Dakar Med; 2008; 53(3):220-7. PubMed ID: 19626794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [For a strict quality of active pharmaceutical ingredients].
    Astier A
    Ann Pharm Fr; 2008 Mar; 66(2):69-70. PubMed ID: 18570901
    [No Abstract]   [Full Text] [Related]  

  • 46. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
    Kelly DP; Bachorik LL
    Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
    [No Abstract]   [Full Text] [Related]  

  • 47. Letter: Discrepancy in article on pharmaceutical quality.
    Hoar ME
    Am J Hosp Pharm; 1976 Jun; 33(6):533. PubMed ID: 1274969
    [No Abstract]   [Full Text] [Related]  

  • 48. U.S., Switzerland oppose developing-country proposal on access to medicines.
    James JS
    AIDS Treat News; 2001 Sep; (371):5. PubMed ID: 11668978
    [No Abstract]   [Full Text] [Related]  

  • 49. [Quality control of drugs in USSR].
    Blazek J
    Cesk Farm; 1974 Jun; 23(5):165-6. PubMed ID: 4458976
    [No Abstract]   [Full Text] [Related]  

  • 50. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. National drug quality assurance system.
    Wijesekera T
    Ceylon Med J; 1993 Jun; 38(2):58-60. PubMed ID: 8370088
    [No Abstract]   [Full Text] [Related]  

  • 52. Quality control and compliance testing.
    Bergen JV
    J Pharm Sci; 1973 Sep; 62(9):VI. PubMed ID: 4743125
    [No Abstract]   [Full Text] [Related]  

  • 53. [Quality control in drugs--an international function].
    Ludwig FA
    Pharm Unserer Zeit; 2002; 31(3):322-6. PubMed ID: 12071130
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug quality control in Kenya--preliminary observations.
    Maitai CK; Tsekpo WM; Wakori E; Wangia C; Mkoji L; Githiga IM
    East Afr Med J; 1982 Jun; 59(6):399-403. PubMed ID: 7173080
    [No Abstract]   [Full Text] [Related]  

  • 55. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
    Subert J; Cizmárik J
    Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current problems in the quality controll of pharmaceutical preparations manufactured in pharmacies I. Identification tests].
    Horváth P; Elekné Vörös Z; Sinkó B; Vámos J; Takácsné Novák K
    Acta Pharm Hung; 2006; 76(2):86-94. PubMed ID: 17094667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [How to assure the quality of a medicinal product ].
    Agosti ME
    Medicina (B Aires); 2003; 63(5):450-2. PubMed ID: 14628657
    [No Abstract]   [Full Text] [Related]  

  • 58. Developing countries and poorest people targeted by UN centre.
    Gershon D
    Nature; 2000 Dec; 408(6813):754. PubMed ID: 11130081
    [No Abstract]   [Full Text] [Related]  

  • 59. The consistency approach for the quality control of vaccines.
    Hendriksen C; Arciniega JL; Bruckner L; Chevalier M; Coppens E; Descamps J; Duchêne M; Dusek DM; Halder M; Kreeftenberg H; Maes A; Redhead K; Ravetkar SD; Spieser JM; Swam H
    Biologicals; 2008 Jan; 36(1):73-7. PubMed ID: 17892948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.